Haemonetics
258 hedge funds and large institutions have $3.36B invested in Haemonetics in 2021 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 102 increasing their positions, 80 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
13% less funds holding
Funds holding: 296 → 258 (-38)
39% less capital invested
Capital invested by funds: $5.49B → $3.36B (-$2.13B)
39% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 87
Holders
258
Holding in Top 10
3
Calls
$20.6M
Puts
$21.3M
Top Buyers
| 1 | +$151M | |
| 2 | +$78.7M | |
| 3 | +$63.5M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$63M |
| 5 |
Neuberger Berman Group
New York
|
+$61.1M |
Top Sellers
| 1 | -$236M | |
| 2 | -$150M | |
| 3 | -$94.6M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$64.9M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$48.9M |